Does use of nonsteroidal anti-inflammatory drugs increase patients' clinical severity of COVID-19?
作者信息
de Oliveira Henrique Souza Barros
机构信息
MD. Physician, Department of Medicine, Centro Universitário São Camilo (CUSC), São Paulo (SP), Brazil.
出版信息
Sao Paulo Med J. 2021 Jul-Aug;139(4):418-419. doi: 10.1590/1516-3180.2021.0401.27052021.
Abstract
摘要
相似文献
1
Does use of nonsteroidal anti-inflammatory drugs increase patients' clinical severity of COVID-19?
Sao Paulo Med J. 2021 Jul-Aug;139(4):418-419. doi: 10.1590/1516-3180.2021.0401.27052021.
2
Non-steroidal anti-inflammatory treatment during covid-19: friend or foe? Response to: 'Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID)' by Giollo .2019冠状病毒病期间的非甾体抗炎治疗：是友是敌？对乔洛的《2019冠状病毒病（COVID-19）与非甾体抗炎药（NSAID）》的回应
Ann Rheum Dis. 2021 Feb;80(2):e13. doi: 10.1136/annrheumdis-2020-217638. Epub 2020 Apr 30.
3
Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID).冠状病毒病19（COVID-19）与非甾体抗炎药（NSAID）
Ann Rheum Dis. 2021 Feb;80(2):e12. doi: 10.1136/annrheumdis-2020-217598. Epub 2020 Apr 22.
4
In adults, NSAID use vs. nonuse in the past 4 mo was not linked to increased risk for COVID-19-related mortality.
Ann Intern Med. 2021 May;174(5):JC58. doi: 10.7326/ACPJ202105180-058. Epub 2021 May 4.
5
Nonsteroidal anti-inflammatory drugs (NSAIDs) consideration by dermatologists during the COVID19 pandemic.皮肤科医生在 COVID-19 大流行期间对非甾体抗炎药（NSAIDs）的考虑。
J Dermatolog Treat. 2022 Mar;33(2):1134-1135. doi: 10.1080/09546634.2020.1800580. Epub 2020 Aug 4.
6
Association Between Nonsteroidal Antiinflammatory Drug Use and Adverse Clinical Outcomes Among Adults Hospitalized With Coronavirus 2019 in South Korea: A Nationwide Study.韩国一项全国性研究显示，在因 2019 年冠状病毒病住院的成年人中，使用非甾体抗炎药与不良临床结局之间存在关联。
Clin Infect Dis. 2021 Dec 6;73(11):e4179-e4188. doi: 10.1093/cid/ciaa1056.
7
Rapid Review: Nonsteroidal Anti-inflammatory Agents and Aminosalicylates in COVID-19 Infections.快速综述：非甾体抗炎药和氨基水杨酸盐在 COVID-19 感染中的作用。
J Clin Gastroenterol. 2020 Aug;54(7):602-605. doi: 10.1097/MCG.0000000000001371.
8
COVID-19 and NSAIDs: Primum non nocere.2019冠状病毒病与非甾体抗炎药：首要的是不伤害。
Therapie. 2020 Sep-Oct;75(5):514-515. doi: 10.1016/j.therap.2020.07.008. Epub 2020 Jul 22.
9
The Use of Nonsteroidal Anti-inflammatory Drugs in Urological Practice in the COVID-19 Era: Is "Safe Better than Sorry"?COVID-19 时代非甾体抗炎药在泌尿外科实践中的应用：“宁安全勿后悔”？
Eur Urol. 2020 Aug;78(2):134-135. doi: 10.1016/j.eururo.2020.03.033. Epub 2020 Apr 10.
10
Nonsteroidal Anti-inflammatory Drugs: A Near-Death Experience.非甾体抗炎药：一次濒死体验
J Clin Rheumatol. 2021 Aug 1;27(5):e170-e171. doi: 10.1097/RHU.0000000000001308.
本文引用的文献
1
Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study.在英国ISARIC临床特征方案队列中，非甾体抗炎药的使用与COVID-19的结局：一项匹配的前瞻性队列研究。
Lancet Rheumatol. 2021 Jul;3(7):e498-e506. doi: 10.1016/S2665-9913(21)00104-1. Epub 2021 May 7.
2
Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts.使用非甾体抗炎药与 COVID-19 死亡风险：基于两个队列的 OpenSAFELY 队列分析。
Ann Rheum Dis. 2021 Jul;80(7):943-951. doi: 10.1136/annrheumdis-2020-219517. Epub 2021 Jan 21.
3
Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study.感染 SARS-CoV-2 的非甾体抗炎药使用者的不良结局和死亡率：一项丹麦全国队列研究。
PLoS Med. 2020 Sep 8;17(9):e1003308. doi: 10.1371/journal.pmed.1003308. eCollection 2020 Sep.
4
Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists.新冠疫情：医生和科学家称布洛芬不应被用于缓解症状。
BMJ. 2020 Mar 17;368:m1086. doi: 10.1136/bmj.m1086.
Zotero 插件